Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves
Overview
Authors
Affiliations
Objective: Calcific aortic valve (AoV) disease is a significant clinical problem for which the regulatory mechanisms are poorly understood. Enhanced cell-cell adhesion is a common mechanism of cellular aggregation, but its role in calcific lesion formation is not known. Cadherin-11 (Cad-11) has been associated with lesion formation in vitro, but its function during adult valve homeostasis and pathogenesis is not known. This study aims to elucidate the specific functions of Cad-11 and its downstream targets, RhoA and Sox9, in extracellular matrix remodeling and AoV calcification.
Approach And Results: We conditionally overexpressed Cad-11 in murine heart valves using a novel double-transgenic Nfatc1(Cre);R26-Cad11(TglTg) mouse model. These mice developed hemodynamically significant aortic stenosis with prominent calcific lesions in the AoV leaflets. Cad-11 overexpression upregulated downstream targets, RhoA and Sox9, in the valve interstitial cells, causing calcification and extensive pathogenic extracellular matrix remodeling. AoV interstitial cells overexpressing Cad-11 in an osteogenic environment in vitro rapidly form calcific nodules analogous to in vivo lesions. Molecular analyses revealed upregulation of osteoblastic and myofibroblastic markers. Treatment with a Rho-associated protein kinase inhibitor attenuated nodule formation, further supporting that Cad-11-driven calcification acts through the small GTPase RhoA/Rho-associated protein kinase signaling pathway.
Conclusions: This study identifies one of the underlying molecular mechanisms of heart valve calcification and demonstrates that overexpression of Cad-11 upregulates RhoA and Sox9 to induce calcification and extracellular matrix remodeling in adult AoV pathogenesis. The findings provide a potential molecular target for clinical treatment.
Unraveling the Enigma of Moderate Aortic Stenosis: Challenges and Future Prospects.
Santangelo G, Tumminello G, Barbieri L, Mallardi G, Faggiano A, Moscardelli S J Clin Med. 2024; 13(12).
PMID: 38930005 PMC: 11204855. DOI: 10.3390/jcm13123478.
Ortega M, De Leon-Oliva D, Gimeno-Longas M, Boaru D, Fraile-Martinez O, Garcia-Montero C Biomolecules. 2024; 14(3).
PMID: 38540696 PMC: 10968665. DOI: 10.3390/biom14030275.
Aortic valve cell microenvironment: Considerations for developing a valve-on-chip.
Tandon I, Ozkizilcik A, Ravishankar P, Balachandran K Biophys Rev (Melville). 2024; 2(4):041303.
PMID: 38504720 PMC: 10903420. DOI: 10.1063/5.0063608.
Cdh11: Roles in different diseases and potential value in disease diagnosis and treatment.
Zhang G, Wang X, Zhang Q Biochem Biophys Rep. 2023; 36:101576.
PMID: 38034129 PMC: 10682823. DOI: 10.1016/j.bbrep.2023.101576.
Immohr M, Teichert H, Dos Santos Adrego F, Schmidt V, Sugimura Y, Bauer S Bioengineering (Basel). 2023; 10(7).
PMID: 37508814 PMC: 10376021. DOI: 10.3390/bioengineering10070787.